PMFA
SRRA

Plante Moran Financial Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Plante Moran Financial Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5
Closed – – 863
2019
Q4 		$0 Buy
+5
New +$65 ﹤0.01% 935
2016
Q3 		– Sell
-106
Closed -$8K – 1010
2016
Q2 		$8K Buy
+106
New +$20.2K 0.01% 565

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Plante Moran Financial Advisors's SRRA Position: Q1 2020 in Review

Plante Moran Financial Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2020, closing a stake of 5 shares.

Plante Moran Financial Advisors first reported a position in SRRA in Q2 2016 and held it in 2 quarters. The position peaked at $8K in Q2 2016. 22 funds tracked by Wall St. Rank hold SRRA as of Q1 2020.

  • Plante Moran Financial Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 5 Sierra Oncology, Inc. Common Stock shares in Q1 2020.
  • Plante Moran Financial Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Plante Moran Financial Advisors's Sierra Oncology, Inc. Common Stock position peaked at $8K in Q2 2016.
  • 22 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2020, filed 7 May 2020.